Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic compounds as TRK kinase inhibitors and uses thereof

Macrocyclic compounds as TRK kinase inhibitors and uses thereof

US Patent 11098046 · Granted Aug 24, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic di-nucleotide compounds as sting agonists2023
Cyclic di-nucleotide compounds as sting agonists2022
Carbamate and urea compounds as multikinase inhibitors2022
Carbamate and urea compounds as multikinase inhibitors2022
Carbamate and urea compounds as multikinase inhibitors2022
Carbamate and urea compounds as multikinase inhibitors2022
Cyclic compounds as immunomodulating agents2021
Cyclic compounds as immunomodulating agents2021
Cyclic compounds as immunomodulating agents2021
Cyclic compounds as immunomodulating agents2021
Insulin dimer-incretin conjugates2021
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as2021